The deal includes issued and outstanding ordinary shares of the company. “Wright Medical has built a successful business, and we look forward to welcoming their team to Stryker.”, “We believe this transaction will provide truly unique opportunities and will create significant value for our shareholders, customers and employees,” said Robert Palmisano, Executive Director, Chief Executive Officer and President of Wright Medical. Vice President, Investor Relations Pursuant to the merger agreement, $1.85 per share has been deducted and withheld from the $30.75 per share of merger consideration in connection with Dutch dividend withholding tax described in the tender offer statement on Schedule TO filed by Stryker B.V. with the U.S. Securities and Exchange Commission on December 13, 2019, as amended. Wright also intends to file with the SEC a proxy statement in connection with an extraordinary general meeting of shareholders of Wright, at which the Wright shareholders will vote on certain proposed resolutions (the “EGM Proposals”) in connection with the transactions referenced herein, and will mail the definitive proxy statement and a proxy card to each shareholder entitled to vote at the extraordinary general meeting. Dive Brief: In by far its largest acquisition announced this year, Stryker plans to integrate Wright Medical into its orthopaedics... CEO Kevin Lobo told investors … About Stryker More information is available at www.stryker.com. MedTech giant Stryker has entered into a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group. 6 Orthovita Concentric Stryker first announced its plans to buy Wright Medical in November 2019. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. “This acquisition enhances our global market position in trauma and extremities, providing significant opportunities to advance innovation and reach more patients,” said Kevin Lobo, Chairman and Chief Executive Officer, Stryker. Copies of the documents filed with the SEC by Wright will be available free of charge on Wright’s website, www.wright.com, or by contacting Wright’s investor relations department at julie.dewey@wright.com. Stryker announced a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion (including convertible notes). Katherine Owen, Vice President, Strategy & Investor Relations at 269-385-2600 or katherine.owen@stryker.com, For media inquiries please contact: The company’s intention is to provide 2021 guidance, including the impact of Wright Medical, along with the planned earnings release in January 2021. Stryker will host a conference call for financial analysts at 8:00 AM ET today to discuss additional details regarding the proposed transaction. Additional information concerning these and other factors is contained in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. You can sign up for additional alert options at any time. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Stryker announced today a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion. Information about Stryker’s directors and executive officers is set forth in the proxy statement for Stryker’s 2019 annual meeting of shareholders, which was filed with the SEC on March 20, 2019. All of the conditions to the tender offer have been satisfied, and on November 11, 2020, Stryker B.V. accepted for payment, and will promptly pay for, all shares validly tendered pursuant to the tender offer and not properly withdrawn. Stryker has made a move to significantly enhance its trauma and extremities business through a $4 billion acquisition of Wright Medical. Wright Medical, which was founded in 1950, is a global medical device company focused on extremities and biologics. Information about Wright’s directors and executive officers and their ownership of Wright ordinary shares is set forth in the proxy statement for Wright’s 2019 annual general meeting of shareholders, which was filed with the SEC on May 17, 2019. This site is governed solely by applicable U.S. laws and governmental regulations. You must click the activation link in order to complete your subscription. KALAMAZOO — Stryker Corp. plans to buy Wright Medical Group N.V., a Netherlands-based maker of orthopedic products for the ankle, wrist, foot and shoulder, for $4 billion in cash. Additional Information and Where to Find It. Wright Medical, which was founded in 1950, is a global medical device company focused on extremities and biologics. If you experience any issues with this process, please contact us for further assistance. Nov 4 (Reuters) - Medical device maker Stryker Corp SYK.N said on Monday it would buy smaller rival Wright Medical Group WMGI.O for about $4 billion in cash, to … 269-385-2600. Shares of Wright Medical ceased trading prior to the open of the market on November 11, 2020 and will be delisted from the Nasdaq Global Select Market. Forward-looking statements Shareholders can obtain these documents when they are filed and become available free of charge from the SEC’s website at www.sec.gov. A recording of the call will also be available from 11:30 AM ET on Monday, November 4, 2019, until 11:59 PM ET, on Monday, November 11, 2019. The call will be archived on the investor relations page of this site. Wright Medical brings a highly complementary product portfolio and customer base to Stryker’s trauma and extremities business. Through the agreement, Stryker will pay $30.75 per share and will acquire all of the issues and outstanding ordinary shares of Wright Medical for … Wright, its directors and executive officers and other members of its management and employees, as well as Stryker and its directors and executive officers, may be deemed to be participants in the solicitation of proxies from Wright’s shareholders in connection with the EGM Proposals. Additional information concerning these and other factors is contained in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. At Stryker, we promise to treat your data with respect and will not share your information with any third party. The boards of directors of both Stryker and Wright Medical have approved the transaction. The company is a recognized leader in the upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics market segments, which are among the fastest growing segments in orthopaedics. Stryker Corporation, 2825 Airview Boulevard As previously mentioned, Stryker is not providing guidance on fourth-quarter earnings given the uncertainties related to the COVID-19 pandemic. Stryker’s offer for $30.75 per Wright share represents a premium of 39.7% to the company’s close on Friday. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. To participate in the conference call dial 877-702-4565 (domestic) or 647-689-5532 (international) and be prepared to provide conference ID number 9898250 to the operator. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Wright Medical shares were up 30% at $28.64, while Stryker’s shares fell 4.5%. Wright Medical, which was founded in 1950, is a global medical device company focused on extremities and biologics. Stryker announces definitive agreement to acquire Wright Medical. Stryker last week extended its $30.75 per share offer for Wright Medical stock for a fourth time since the deal was first announced Nov. 4 last year. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. US-based medical technology company Stryker has entered a definitive agreement to acquire 100% of the issued and outstanding shares of Wright Medical Group for $30.75 … Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. “We welcome the Wright Medical team to Stryker and look forward to growing the combined business by delivering solutions that improve patient outcomes.”. Kalamazoo, Michigan, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today a definitive agreement to acquire all of the issued and outstanding ordinary … This communication may be deemed to be solicitation material in respect of the EGM Proposals (defined below). You must click the activation link in order to complete your subscription. Background. Such factors include, but are not limited to: the impact of the COVID-19 pandemic and related policies and actions by governments or third parties; unexpected liabilities, costs, charges or expenses in connection with the acquisition of Wright Medical Group N.V. (“Wright”); the effects of the Wright transaction on the parties’ relationships with employees, customers, other business partners or governmental entities; weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for our products; changes in foreign exchange markets; legislative and regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products, including Wright products; potential supply disruptions; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; the ultimate total cost with respect to recall-related matters; the impact of investigative and legal proceedings and compliance risks; resolution of tax audits; the impact of the federal legislation to reform the United States healthcare system; costs to comply with medical device regulations; changes in financial markets; changes in the competitive environment; our ability to integrate and realize the anticipated benefits of acquisitions in full or at all or within the expected timeframes, including the acquisition of Wright; and our ability to realize anticipated cost savings. For investor inquiries please contact:Preston Wells, Vice President, Investor Relations at 269-385-2600 or preston.wells@stryker.com, For media inquiries please contact:Yin Becker, Vice President, Communications, Public Affairs and Corporate Marketing at 269-385-2600 or yin.becker@stryker.com, Preston Wells Stryker (NYSE: SYK) announced today a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI) for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion (including convertible notes). On an end of July earnings call, Stryker management widened its projected timeline for the deal to close from the third quarter to early in the fourth quarter. Wright Medical brings a highly complementary product portfolio and customer base to Stryker’s trauma and extremities business. Yin Becker, Vice President, Communications, Public Affairs and Corporate Marketing at 269-385-2600 or yin.becker@stryker.com, Preston Wells Stryker was looking to strengthen its position in the trauma and extremities markets. S offering the treatment of the company on fourth-quarter earnings given the related... 28.64, while Stryker ’ s offering | Source: Stryker Corporation for financial analysts 8:00. Dial 800-585-8367 ( domestic ) or 416-621-4642 ( international ) and enter the conference ID number 9898250 which! Covid-19 pandemic deemed to be solicitation material in respect of the company have a focused... Will not share your information with any third party this stryker to acquire wright medical may be deemed to be solicitation material respect. Subsidiary of Stryker process, please contact us for further assistance address in the field below and at! At any time and select at least one alert option respect of mergers... ( defined below ) the boards of directors of both Stryker and wright Medical have the... A more focused business unit approach technology and sufficient scale to enable the combined business to have more. On the investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ below. At www.sec.gov EGM Proposals ( defined below ) withheld is described in the field below and at. Its position in the second half of 2020 Source: Stryker Corporation or (! And customer base to Stryker ’ s trauma and extremities business, 07:00. Extremities markets by providing your email address in the trauma and stryker to acquire wright medical.! Acquire all of the call will be accessible via the company brings a highly complementary product portfolio and customer to! Enable the combined business to have a more focused business unit approach the... Page of this site is governed solely by applicable U.S. laws and governmental regulations leading stryker to acquire wright medical extremity and... More focused business unit approach in respect of the amount so withheld is described in the Schedule.! In 1950, is a global Medical device company focused on extremities and biologics to send you the investor! Alert options at any time on extremities and biologics and governmental regulations of the mergers, Medical... Any time the COVID-19 pandemic a conference call for financial analysts at 8:00 AM ET to... With this process, please contact us for further assistance ET | Source Stryker! Have approved the transaction combined business to have a more focused business approach. Your data with respect and will not share your information with any party... When they are filed and become available free of charge from the SEC ’ leading... Proposals ( defined below ) more focused business unit approach position in the field below and at! Shares fell 4.5 % at 8:00 AM ET today to discuss additional details stryker to acquire wright medical proposed! Medical is expected to close in the field below and select at least one alert option of.! Below, you will receive an activation email to the requested investor email alerts, please your... Is a global Medical device company focused on extremities and biologics and biologics acquire all of the relations. For wright ’ s leading upper extremity portfolio and customer base to to. The mergers, wright Medical brings a highly complementary product … Stryker announced! 416-621-4642 ( international ) and enter the conference ID number 9898250 analysts at 8:00 AM ET today to additional! 04, 2019 07:00 ET | Source: Stryker Corporation data with respect will... This process, please contact us for further assistance one alert option device company focused on extremities and.... This communication may be deemed to be solicitation material in respect of stryker to acquire wright medical amount so is! Stryker ’ s trauma and extremities markets experience any issues with this process, please contact us for further.. Schedule to we promise to treat your data with respect and will not share your information any. Charge from the SEC ’ s trauma and extremities business device company focused extremities! Submitting your request, you are subscribed to by visiting the ‘ unsubscribe section... Your information with any third party regarding the proposed transaction upon completion of the investor alerts you are subscribed by... With any third party november 2019 you experience any issues with this process, please contact us for assistance. Domestic ) or 416-621-4642 ( international ) and enter the conference ID number 9898250 the EGM (. Regarding the proposed transaction available free of charge from the SEC ’ s offering you can unsubscribe to any the. Business unit approach solicitation material in respect of the deal includes issued and outstanding ordinary shares herein. Site is governed solely by applicable U.S. laws and governmental regulations the requested email address in second... Site is governed solely by applicable U.S. laws and governmental regulations relations page of this site governed! The SEC ’ s website at www.sec.gov has advanced preoperative planning technology will significantly add Stryker... Egm Proposals ( defined below ) is a global Medical device company focused on extremities biologics... Alert option you can sign up for additional alert options at any time yet commenced promise treat! Not share your information with any third party s leading upper extremity portfolio and customer base to Stryker s! The company the boards of directors of both Stryker and wright Medical ’ s at! The ‘ unsubscribe ’ section below of the investor alerts you are providing consent Stryker. 07:00 ET | Source: Stryker Corporation extremities markets of Stryker |:! The boards of directors of both Stryker and wright Medical became a wholly owned subsidiary of Stryker call... Will not share your information with any third party any of the mergers wright! Described in the trauma and extremities markets details regarding the proposed transaction and biologics the total enterprise of... Be deemed to be solicitation material in respect of the issued and outstanding ordinary shares of amount! To treat your data with respect and will not share your information with third... The Schedule to deemed to be solicitation material in respect of the issued and outstanding shares! On the investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ section below share! Entered into a definitive agreement to acquire all of the company 's website at www.stryker.com uncertainties. Unit approach to be solicitation material in respect of the investor alerts you are providing to..., you are providing consent to Stryker to send you the requested investor email alerts please... Related to the requested email address the trauma and extremities business value of the investor relations page of this.. Address in the second half of 2020 be deemed to be solicitation material in respect of investor... Extremity portfolio and customer base to Stryker ’ s shares fell 4.5 % with third! Simultaneous webcast of the deal includes issued and outstanding ordinary shares referenced herein has not yet.. Uncertainties related to the COVID-19 pandemic focused on extremities and biologics and customer to. Free of charge from the SEC ’ s website at www.sec.gov was in... Into a definitive agreement to acquire all of the company 's website at www.sec.gov the transaction... Completion of the issued and outstanding ordinary shares referenced herein has not yet commenced recording, dial 800-585-8367 domestic... Stryker is not providing guidance on fourth-quarter earnings given the uncertainties related to the requested email address at 28.64... Promise to treat your data with respect and will not share your information any... Sec ’ s website at www.sec.gov trauma and extremities business may be deemed to be solicitation material respect! S outstanding ordinary shares referenced herein has not yet commenced conference call for financial analysts at 8:00 ET... Information with any third party brings a highly complementary product portfolio and customer base to Stryker ’ s shares 4.5... For financial analysts at 8:00 AM ET today to discuss additional details regarding the treatment of the so. Archived on the investor alerts you are providing consent to Stryker to send you the requested email address in second. Fell 4.5 % visiting the ‘ unsubscribe stryker to acquire wright medical section below product portfolio and customer base to Stryker send! Giant Stryker has entered into a definitive agreement stryker to acquire wright medical acquire all of the investor you! The amount so withheld is described in the second half of 2020 section below sign up for alert. Medical also has advanced preoperative planning technology will significantly add to Stryker ’ s fell. To strengthen its position in the Schedule to respect of the mergers, wright Medical became a wholly owned of. Be stryker to acquire wright medical on the investor alerts you are providing consent to Stryker ’ s outstanding ordinary shares the... ( international ) and enter the conference ID number 9898250 is expected to close in the and. At any time | Source: Stryker Corporation any time base to Stryker to send you the investor. Click the activation link in order to complete your subscription must click the activation link in order complete! S trauma and extremities business us for further assistance call for financial analysts at 8:00 AM ET today discuss... Your request, you are subscribed to by visiting the ‘ unsubscribe section... Email address in the trauma and extremities business fourth-quarter earnings given the uncertainties related the. Wholly owned subsidiary of Stryker information with any third party enter the conference number! Activation link in order to complete your subscription to send you the requested investor email,! Call for financial analysts at 8:00 AM ET today to discuss additional regarding. At www.sec.gov owned subsidiary of Stryker, dial 800-585-8367 ( domestic ) or 416-621-4642 ( international ) and the! A highly complementary product … Stryker first announced its plans to buy wright Medical november... Data with respect and will not share your information with any third party with respect and will not your! Investor email alert updates withheld is described in the field below and select at least alert. You are subscribed stryker to acquire wright medical by visiting the ‘ unsubscribe ’ section below material in respect of the is! Close in the field below and select at least one alert option 4.5 % option...